# The protein corona and the fate of a nanoparticle in the body

> What the body sees is not the particle you made. Within half a minute of meeting plasma a nanoparticle wears a corona of proteins; higher-affinity proteins then displace the first arrivals and a hard and a soft corona settle. Opsonins hand it to macrophages unless a PEG brush hides it, and most of a dose ends in the liver: 30–99 % for hard nanomaterials, a median 0.7 % in tumours, and only particles under 5.5 nm leave through the kidneys.

- Page: https://www.labcanvas.com/templates/graphical-abstracts/protein-corona-fate-nanoparticle-body
- Open in the LabCanvas editor (LabCanvas account): https://www.labcanvas.com/editor.html?template=protein-corona-fate-of-a-nanoparticle-in-the-body
- Updated: 2026-10-14
- Category: Graphical abstracts
- Method: Graphical abstract
- Starting materials: A nanoparticle entering blood plasma
- Product: The particle’s biological identity (its corona) and where it ends up
- Key result: Corona in < 0.5 min (Tenzer et al. 2013); liver 30–99 % (Tsoi et al. 2016); renal cut-off 5.5 nm (Choi et al. 2007); tumour 0.7 % median (Wilhelm et al. 2016)
- Figure: 1920 × 1080 px, 39 editable layers (5 generated objects with settings)

## Steps

1. **Corona in seconds**: Plasma coronas form in under half a minute and then change more in amount than in composition (Tenzer et al. 2013); the corona is the particle’s biological identity (Monopoli et al. 2012)
2. **Affinity wins**: Proteins compete for the surface (Cedervall et al. 2007); fibrinogen displaces albumin on gold (Vroman effect); a hard, irreversible corona under a soft, exchangeable one (Gupta & Roy 2020)
3. **Eaten or hidden**: Opsonins mark particles for MPS macrophages; a PEG brush repels them and prolongs circulation (Owens & Peppas 2006; Gref et al. 1994)
4. **Where the dose goes**: Liver 30–99 % for hard nanomaterials (Tsoi et al. 2016); kidneys only below a 5.5 nm hydrodynamic diameter (Choi et al. 2007); a median 0.7 % reaches solid tumours (Wilhelm et al. 2016)

## Uses

- Graphical abstracts on the nano–bio interface and the protein corona
- Nanomedicine reviews on biodistribution and clearance
- Teaching why PEGylation matters

## References

1. Monopoli et al., “Biomolecular coronas provide the biological identity of nanosized materials”, Nat. Nanotechnol. 2012. https://doi.org/10.1038/nnano.2012.207 (primary)
2. Tenzer et al., “Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology”, Nat. Nanotechnol. 2013. https://doi.org/10.1038/nnano.2013.181 (primary)
3. Cedervall et al., “Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles”, Proc. Natl. Acad. Sci. USA 2007. https://doi.org/10.1073/pnas.0608582104 (primary)
4. Walkey et al., “Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake”, J. Am. Chem. Soc. 2012. https://doi.org/10.1021/ja2084338 (primary)
5. Gupta & Roy, “How corona formation impacts nanomaterials as drug carriers”, Mol. Pharm. 2020. https://doi.org/10.1021/acs.molpharmaceut.9b01111 (review)
6. Owens & Peppas, “Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles”, Int. J. Pharm. 2006. https://doi.org/10.1016/j.ijpharm.2005.10.010 (review)
7. Gref et al., “Biodegradable long-circulating polymeric nanospheres”, Science 1994. https://doi.org/10.1126/science.8128245 (method origin)
8. Gref et al., “'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption”, Colloids Surf. B 2000. https://doi.org/10.1016/s0927-7765(99)00156-3 (primary)
9. Tsoi et al., “Mechanism of hard-nanomaterial clearance by the liver”, Nat. Mater. 2016. https://doi.org/10.1038/nmat4718 (primary)
10. Choi et al., “Renal clearance of quantum dots”, Nat. Biotechnol. 2007. https://doi.org/10.1038/nbt1340 (primary)
11. Wilhelm et al., “Analysis of nanoparticle delivery to tumours”, Nat. Rev. Mater. 2016. https://doi.org/10.1038/natrevmats.2016.14 (primary)

Credit: Drawn by LabCanvas after Monopoli et al., Nat. Nanotechnol. 2012 (doi:10.1038/nnano.2012.207); Tenzer et al., Nat. Nanotechnol. 2013 (doi:10.1038/nnano.2013.181); Cedervall et al., PNAS 2007 (doi:10.1073/pnas.0608582104); Gupta & Roy, Mol. Pharm. 2020 (doi:10.1021/acs.molpharmaceut.9b01111); Walkey et al., J. Am. Chem. Soc. 2012 (doi:10.1021/ja2084338); Owens & Peppas, Int. J. Pharm. 2006 (doi:10.1016/j.ijpharm.2005.10.010); Tsoi et al., Nat. Mater. 2016 (doi:10.1038/nmat4718); Choi et al., Nat. Biotechnol. 2007 (doi:10.1038/nbt1340); Wilhelm et al., Nat. Rev. Mater. 2016 (doi:10.1038/natrevmats.2016.14). Schematic, not to scale.

## Questions

**What does the “The protein corona and the fate of a nanoparticle in the body” template show?** What the body sees is not the particle you made. Within half a minute of meeting plasma a nanoparticle wears a corona of proteins; higher-affinity proteins then displace the first arrivals and a hard and a soft corona settle. Opsonins hand it to macrophages unless a PEG brush hides it, and most of a dose ends in the liver: 30–99 % for hard nanomaterials, a median 0.7 % in tumours, and only particles under 5.5 nm leave through the kidneys.

**What are the steps shown in “The protein corona and the fate of a nanoparticle in the body”?** 1. Corona in seconds: Plasma coronas form in under half a minute and then change more in amount than in composition (Tenzer et al. 2013); the corona is the particle’s biological identity (Monopoli et al. 2012). 2. Affinity wins: Proteins compete for the surface (Cedervall et al. 2007); fibrinogen displaces albumin on gold (Vroman effect); a hard, irreversible corona under a soft, exchangeable one (Gupta & Roy 2020). 3. Eaten or hidden: Opsonins mark particles for MPS macrophages; a PEG brush repels them and prolongs circulation (Owens & Peppas 2006; Gref et al. 1994). 4. Where the dose goes: Liver 30–99 % for hard nanomaterials (Tsoi et al. 2016); kidneys only below a 5.5 nm hydrodynamic diameter (Choi et al. 2007); a median 0.7 % reaches solid tumours (Wilhelm et al. 2016).

**What are the starting materials and the product?** Starting materials: A nanoparticle entering blood plasma. Product: The particle’s biological identity (its corona) and where it ends up.

**Which papers is “The protein corona and the fate of a nanoparticle in the body” based on?** Monopoli et al., “Biomolecular coronas provide the biological identity of nanosized materials”, Nat. Nanotechnol. 2012 (doi:10.1038/nnano.2012.207); Tenzer et al., “Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology”, Nat. Nanotechnol. 2013 (doi:10.1038/nnano.2013.181); Cedervall et al., “Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles”, Proc. Natl. Acad. Sci. USA 2007 (doi:10.1073/pnas.0608582104); Walkey et al., “Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake”, J. Am. Chem. Soc. 2012 (doi:10.1021/ja2084338); Gupta & Roy, “How corona formation impacts nanomaterials as drug carriers”, Mol. Pharm. 2020 (doi:10.1021/acs.molpharmaceut.9b01111); Owens & Peppas, “Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles”, Int. J. Pharm. 2006 (doi:10.1016/j.ijpharm.2005.10.010); Gref et al., “Biodegradable long-circulating polymeric nanospheres”, Science 1994 (doi:10.1126/science.8128245); Gref et al., “'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption”, Colloids Surf. B 2000 (doi:10.1016/s0927-7765(99)00156-3); Tsoi et al., “Mechanism of hard-nanomaterial clearance by the liver”, Nat. Mater. 2016 (doi:10.1038/nmat4718); Choi et al., “Renal clearance of quantum dots”, Nat. Biotechnol. 2007 (doi:10.1038/nbt1340); Wilhelm et al., “Analysis of nanoparticle delivery to tumours”, Nat. Rev. Mater. 2016 (doi:10.1038/natrevmats.2016.14).

**Can I edit the “The protein corona and the fate of a nanoparticle in the body” template?** Yes. Open it in the LabCanvas editor: all 39 layers are editable, including 5 generated objects (structures, plots, equipment) with their own settings. Change the text, colours and layout, then export PNG, TIFF or PDF at the width and DPI the journal asks for.

**Do I need an account to use this template?** Not to view it here. To open and edit it, sign in to LabCanvas or create a free account (the free plan keeps up to 3 designs). Downloading the figure is part of LabCanvas Pro (US$19 a month or US$199 a year).
